Cargando…

Prevalence of comorbidities and their associated factors in patients with type 2 diabetes at a tertiary care department in Ningbo, China: a cross-sectional study

OBJECTIVES: To determine the prevalence of comorbidities in patients with type 2 diabetes mellitus (T2DM) and identify the factors independently associated with comorbidities in a tertiary care department in Ningbo, China. DESIGN: A computerised medical records database was used to conduct a cross-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xueyu, Chattopadhyay, Kaushik, Xu, Shengnan, Chen, Yanshu, Xu, Miao, Li, Li, Li, Jialin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797259/
https://www.ncbi.nlm.nih.gov/pubmed/33414143
http://dx.doi.org/10.1136/bmjopen-2020-040532
_version_ 1783634832210788352
author Li, Xueyu
Chattopadhyay, Kaushik
Xu, Shengnan
Chen, Yanshu
Xu, Miao
Li, Li
Li, Jialin
author_facet Li, Xueyu
Chattopadhyay, Kaushik
Xu, Shengnan
Chen, Yanshu
Xu, Miao
Li, Li
Li, Jialin
author_sort Li, Xueyu
collection PubMed
description OBJECTIVES: To determine the prevalence of comorbidities in patients with type 2 diabetes mellitus (T2DM) and identify the factors independently associated with comorbidities in a tertiary care department in Ningbo, China. DESIGN: A computerised medical records database was used to conduct a cross-sectional study. SETTING: The study was conducted in a tertiary care department in Ningbo, China. PARTICIPANTS: The study was conducted on adult patients with T2DM, and it included 8 years of data, from 1 January 2012 to 31 December 2019. THE PRIMARY OUTCOME MEASURE: Comorbidity was defined as the coexistence of at least one other chronic condition, that is, either a physical non-communicable disease (duration ≥3 months), a mental health condition (duration ≥3 months) or an infectious disease (duration ≥3 months). RESULTS: In total, 4777 patients with T2DM satisfied the eligibility criteria. Over 8 years, the prevalence of comorbidities was 93.7%. The odds of comorbidities increased with the age of patients (18 to 39 years: 1; 40 to 59 years: OR 2.80, 95% CI 1.98 to 3.96; 60 to 69 years: OR 4.43, 95% CI 3.04 to 6.44; and ≥70 years: OR 10.97, 95% CI 7.17 to 16.77). The odds were lower in female patients (OR 0.66, 95% CI 0.51 to 0.84), patients residing in rural areas (OR 0.75, 95% CI 0.59 to 0.95) and patients without health insurance (OR 0.62, 95% CI 0.46 to 0.83). The odds were higher in single/divorced/widowed patients compared with those in married patients (OR 1.95, 95% CI 1.21 to 3.12). CONCLUSIONS: A large percentage of patients with T2DM in the tertiary care department in Ningbo, China, had comorbidities, and the factors associated with comorbidities were identified. The findings could be used in developing, evaluating and implementing interventions aimed at improving outcomes in patients with T2DM with comorbidities.
format Online
Article
Text
id pubmed-7797259
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-77972592021-01-21 Prevalence of comorbidities and their associated factors in patients with type 2 diabetes at a tertiary care department in Ningbo, China: a cross-sectional study Li, Xueyu Chattopadhyay, Kaushik Xu, Shengnan Chen, Yanshu Xu, Miao Li, Li Li, Jialin BMJ Open Diabetes and Endocrinology OBJECTIVES: To determine the prevalence of comorbidities in patients with type 2 diabetes mellitus (T2DM) and identify the factors independently associated with comorbidities in a tertiary care department in Ningbo, China. DESIGN: A computerised medical records database was used to conduct a cross-sectional study. SETTING: The study was conducted in a tertiary care department in Ningbo, China. PARTICIPANTS: The study was conducted on adult patients with T2DM, and it included 8 years of data, from 1 January 2012 to 31 December 2019. THE PRIMARY OUTCOME MEASURE: Comorbidity was defined as the coexistence of at least one other chronic condition, that is, either a physical non-communicable disease (duration ≥3 months), a mental health condition (duration ≥3 months) or an infectious disease (duration ≥3 months). RESULTS: In total, 4777 patients with T2DM satisfied the eligibility criteria. Over 8 years, the prevalence of comorbidities was 93.7%. The odds of comorbidities increased with the age of patients (18 to 39 years: 1; 40 to 59 years: OR 2.80, 95% CI 1.98 to 3.96; 60 to 69 years: OR 4.43, 95% CI 3.04 to 6.44; and ≥70 years: OR 10.97, 95% CI 7.17 to 16.77). The odds were lower in female patients (OR 0.66, 95% CI 0.51 to 0.84), patients residing in rural areas (OR 0.75, 95% CI 0.59 to 0.95) and patients without health insurance (OR 0.62, 95% CI 0.46 to 0.83). The odds were higher in single/divorced/widowed patients compared with those in married patients (OR 1.95, 95% CI 1.21 to 3.12). CONCLUSIONS: A large percentage of patients with T2DM in the tertiary care department in Ningbo, China, had comorbidities, and the factors associated with comorbidities were identified. The findings could be used in developing, evaluating and implementing interventions aimed at improving outcomes in patients with T2DM with comorbidities. BMJ Publishing Group 2021-01-07 /pmc/articles/PMC7797259/ /pubmed/33414143 http://dx.doi.org/10.1136/bmjopen-2020-040532 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Diabetes and Endocrinology
Li, Xueyu
Chattopadhyay, Kaushik
Xu, Shengnan
Chen, Yanshu
Xu, Miao
Li, Li
Li, Jialin
Prevalence of comorbidities and their associated factors in patients with type 2 diabetes at a tertiary care department in Ningbo, China: a cross-sectional study
title Prevalence of comorbidities and their associated factors in patients with type 2 diabetes at a tertiary care department in Ningbo, China: a cross-sectional study
title_full Prevalence of comorbidities and their associated factors in patients with type 2 diabetes at a tertiary care department in Ningbo, China: a cross-sectional study
title_fullStr Prevalence of comorbidities and their associated factors in patients with type 2 diabetes at a tertiary care department in Ningbo, China: a cross-sectional study
title_full_unstemmed Prevalence of comorbidities and their associated factors in patients with type 2 diabetes at a tertiary care department in Ningbo, China: a cross-sectional study
title_short Prevalence of comorbidities and their associated factors in patients with type 2 diabetes at a tertiary care department in Ningbo, China: a cross-sectional study
title_sort prevalence of comorbidities and their associated factors in patients with type 2 diabetes at a tertiary care department in ningbo, china: a cross-sectional study
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797259/
https://www.ncbi.nlm.nih.gov/pubmed/33414143
http://dx.doi.org/10.1136/bmjopen-2020-040532
work_keys_str_mv AT lixueyu prevalenceofcomorbiditiesandtheirassociatedfactorsinpatientswithtype2diabetesatatertiarycaredepartmentinningbochinaacrosssectionalstudy
AT chattopadhyaykaushik prevalenceofcomorbiditiesandtheirassociatedfactorsinpatientswithtype2diabetesatatertiarycaredepartmentinningbochinaacrosssectionalstudy
AT xushengnan prevalenceofcomorbiditiesandtheirassociatedfactorsinpatientswithtype2diabetesatatertiarycaredepartmentinningbochinaacrosssectionalstudy
AT chenyanshu prevalenceofcomorbiditiesandtheirassociatedfactorsinpatientswithtype2diabetesatatertiarycaredepartmentinningbochinaacrosssectionalstudy
AT xumiao prevalenceofcomorbiditiesandtheirassociatedfactorsinpatientswithtype2diabetesatatertiarycaredepartmentinningbochinaacrosssectionalstudy
AT lili prevalenceofcomorbiditiesandtheirassociatedfactorsinpatientswithtype2diabetesatatertiarycaredepartmentinningbochinaacrosssectionalstudy
AT lijialin prevalenceofcomorbiditiesandtheirassociatedfactorsinpatientswithtype2diabetesatatertiarycaredepartmentinningbochinaacrosssectionalstudy